Sign Up | Log In | What is SocialPicks?

Please sign up for SocialPicks site access - it's free!

3 pts

Opinion on Nektar Therapeutics (NKTR) Sector: Healthcare > Industry: Medical Equipment & Supplies
BUY: Nektar Therapeutics (NKTR)

Feb 06, 2007 09:15 AM GMT

fivepercentstocks

Return	Risk
-17.69%	HIGH

Tracked Blogger

Profile & Performance

Subscribe to author

Via www.fivepercentstocks.com:

BUY: Nektar Therapeutics (NKTR): $14.01 (1/12/07) Sell price: $15.21 or Sell date: February 12, 2007Trailing stop: $13.25 (-5.4%) Oversold, odds favor long trades.Strong Down trend (1 month), not sustainable, occurs only 15% of the time, expect trend to turn sideways or higher.Analyst sentiment at around $19. Profile: Nektar Therapeutics is a biopharmaceutical company. The Company [...]

... Read the rest of the original post >

This is a tracking account [?] SocialPicks is not affiliated with fivepercentstocks. The POS/NEG sentiment is automatically determined by SocialPicks from this blog post and should not be recognized as a position recommendation by fivepercentstocks

NKTR: This call was made on 02/06/07 @ $12.2

Rating:	$12.2 (02/06/07)
Gain/Loss:	-26.97% in 1007 days

Add Comment

Be the first to comment on this story and earn 2 points.

Your Comment

ROCK-STAR INVESTORS

Rank	Name	Sharpe Ratio	Avg Return	Followers
1	noshoes	21.10	+34.56%	369
2	Gerald Greene	18.14	+69.43%	206
3	stockmarketfunding.com	17.66	+25.71%	53
4	akiralegrand	13.47	+14.32%	61
5	anup2104	12.13	+75.75%	34

... more »

POPULAR STOCKS

Symbol	Company Name	Sentiment
EBAY	eBay Inc
C	Citigroup Inc
NVDA	NVIDIA Corp
GE	General Electric Company
FRE	Freddie Mac
WM	Washington Mutual Inc

... more »

TODAY'S HEADLINES

LDK Solar's Growth Potential Offset by Gross Margin Pressure
by Paul Cheung (Zacks.com) about LDK

Cisco Systems Still a Wait and See
by Thomas Catino (Ant & Sons) about CSCO

The Merrill Lynch Diet: Starving Shareholders
by Zack Miller (BloggingStocks) about MER

Until Housing Improves, Don't Expect Stocks to Rebound
by J.D. Steinhilber (Agile Investing) about SPY

Google Blows Q2: Multiple Compression to Continue
by Henry Blodget about GOOG

... more »

TODAY'S TOP PICKS

TTWO		Take Two on Take Two Interactive by jgarner3999
F		take the money and run by benkschroeder
NPD		NPD - CHINA NEPSTAR POISED FOR SIGNIFICANT GROWTH by penny7
EXAS		EXACT Sciences (NASDAQ: EXAS): Buy and Hold for Long-Term Upside by Mike Havrilla
DNDN		New Global Equity Index to Track Immunotherapy, Vaccine Stocks by Mike Havrilla

... more »

Nektar Therapeutics (NKTR)

SocialPicks Sentiment: N/A

This Quarter's Sentiment:

All:

0.0%

Top:

0.0%

Get Daily Email Alerts

Subscribe to fivepercentstocks

Receive Free Ideas Daily for This Sector

Latest Picks by fivepercentstocks

Symbol	SP Sentiment	Return	Since
URBN		+40.00%	08/09/07
SXE	N/A	+37.83%	08/07/07
STLY	N/A	+52.93%	08/07/07
SWK		+8.11%	08/07/07
ISL	N/A	-36.71%	07/21/07

View All >

IN THE PRESS

None of the information contained on SocialPicks.com constitutes a recommendation by SocialPicks or its users that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. SocialPicks is not responsible for the posts, discussions, and recommendations of the users on the Site. SocialPicks does not provide investment advice. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the website. SocialPicks' users' past results are not necessarily indicative of future performance. Neither SocialPicks nor any of its users guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the website. You understand and agree that you use the Site and Services at your own discretion and risk and that you will be solely responsible for any damages that arise from such use. Before acting on any information contained on the website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.

Opinion on Nektar Therapeutics (NKTR) Sector: Healthcare > Industry: Medical Equipment & Supplies BUY: Nektar Therapeutics (NKTR)

Opinion on Nektar Therapeutics (NKTR) Sector: Healthcare > Industry: Medical Equipment & Supplies
BUY: Nektar Therapeutics (NKTR)